CMP: 248

Elder Pharmaceuticals Limited operates a pharmaceutical company in India. The Company manufactures an assortment of pharmaceutical, healthcare and surgical products, as well as medical devices and industrial goods. Elder's range of pharmaceutical products include antibiotics, anti-inflammatories and vitamins, in addition to a variety of wound and skin care remedies.

Elder Pharma is a decent bet in small-cap pharma space trading at a P/E of over 5 with dividend yields of over 1% in the last 12 months. It runs at a debt of 780 Crores with 129 Crores cash in hand. Revenues have risen from 548 Crores to 982 Crores in the last 5 years. Profits have risen from 71 Crores to 85 Crores in the last 5 years. Profit margins have slipped from 13% to below 9% in the last 5 years. Its not a growth pick, but a decent bet to buy and current levels to book profits at higher levels. 82% of promoter stake is pledged which is a concern.